Enhancement of human neutrophil responses to platelet activating factor by 5(S)-hydroxy-eicosatetraenoate

J Lipid Mediat. 1991 Sep-Oct;4(2):165-74.

Abstract

5(S)-hydroxy-eicosatetraenoate (5(S)-HETE) enhanced the ability of platelet-activating factor (PAF) to stimulate neutrophil inositol phospholipid turnover, Ca2+ transients, superoxide anion generation, and degranulation. It did not alter responses to leukotriene B4, N-formyl-methionylleucylphenylalanine, or ionomycin. Moreover, 5(R)- and 15(S)-HETE had little effect on PAF. 5(S)-HETE thus acted stereospecifically and stimulus-selectively to potentiate early occurring transductional events as well as later occurring functional responses to PAF. The HETE may influence the actions of PAF by up-regulating PAF receptors and/or these receptors' linkages with the G-protein/phospholipase C axis.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Diglycerides / metabolism
  • Drug Synergism
  • Humans
  • Hydrolysis
  • Hydroxyeicosatetraenoic Acids / metabolism
  • Hydroxyeicosatetraenoic Acids / pharmacology*
  • Inositol Phosphates / metabolism
  • Neutrophils / drug effects*
  • Neutrophils / metabolism
  • Phosphatidylinositol 4,5-Diphosphate
  • Phosphatidylinositols / metabolism
  • Platelet Activating Factor / pharmacology*
  • Superoxides / metabolism

Substances

  • Diglycerides
  • Hydroxyeicosatetraenoic Acids
  • Inositol Phosphates
  • Phosphatidylinositol 4,5-Diphosphate
  • Phosphatidylinositols
  • Platelet Activating Factor
  • Superoxides
  • 5-hydroxy-6,8,11,14-eicosatetraenoic acid